WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Serious about science: Serious about timing
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 31, 2004, 24(13):3235-3241; doi:10.1523/JNEUROSCI.0112-04.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (52)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Deurwaerdère, P.
Right arrow Articles by Spampinato, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Deurwaerdère, P.
Right arrow Articles by Spampinato, U.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens

Philippe De Deurwaerdère,1 Sylvia Navailles,1 Kelly A Berg,2 William P. Clarke,2 and Umberto Spampinato1

1Unité Mixte de Recherche Centre National de la Recherche Scientifique 5541–Université Victor Segalen Bordeaux 2, Boîte Postale 31, 33076 Bordeaux Cedex, France, and 2Department of Pharmacology, University of Texas, Health Science Center, San Antonio, Texas 78229-3900

Numerous research has pointed out that serotonin2c (5-HT2C) receptor, a subtype of 5-HT receptors belonging to the G-protein-coupled receptor superfamily, modulates the activity of mesencephalic dopamine (DA) neurons, the dysfunction of which is involved in devastating diseases such as schizophrenia, Parkinson's disease, and drug addiction. In the present study, using in vivo intracerebral microdialysis and Chinese hamster ovary (CHO) cells expressing 5-HT2C receptors to identify appropriate 5-HT2C receptor ligands, we sought to determine whether the property of 5-HT2C receptors to spontaneously activate intracellular signaling pathways in vitro (constitutive activity) participates in the tonic inhibitory control that they exert on DA release in the rat striatum and nucleus accumbens in vivo. In CHO cells, the purported antagonist 5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f] indole hydrochloride (SB 206553), but not 6-chloro-5-methyl-1-[6-(2-methylpiridin-3-yloxy)pyridin-3-yl carbamoyl] indoline (SB 242084), decreased basal inositol phosphate accumulation, thus behaving as a 5-HT2C inverse agonist. Its effect was prevented by SB 242084. In vivo, SB 206553 (1–10 mg/kg) elicited a dose-dependent and clear-cut increase in accumbal and striatal DA release compared with SB 242084 (1–10 mg/kg), and the 5-HT2C agonist S-2-(6-chloro-5-fluoroindol-1-yl)-1-methylethylamine hydrochloride (Ro-60-0175) (0.3–3 mg/kg) inhibited DA release. Pretreatment by SB 242084 reversed the change in DA release elicited by Ro-60-0175 and SB 206553. Furthermore, SB 206553-stimulated DA release was insensitive to reduction of 5-HT neuronal function induced by the 5-HT1A agonist (±)-8-hydroxy-2-dipropylaminotetralin or intra-raphe injections of 5,7-dihydroxytryptamine neurotoxin. The obtained results provide the first in vivo evidence that constitutive activity of the 5-HT2C receptor tonically inhibits mesencephalic DA neurons and underscore the need for a better understanding of the pathophysiological role of constitutive receptor activity.

Key words: DA release; striatum; nucleus accumbens; 5-HT2C receptor; rat; constitutive activity


Received Sep 16, 2003; revised February 13, 2004; accepted February 13, 2004.




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Janssens, M. Boussemaere, S. Wagner, K. Kopka, and C. Denef
{beta}1-Adrenoceptors in Rat Anterior Pituitary May Be Constitutively Active. Inverse Agonism of CGP 20712A on Basal 3',5'-Cyclic Adenosine 5'-Monophosphate Levels
Endocrinology, May 1, 2008; 149(5): 2391 - 2402.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Chanrion, C. M. la Cour, S. Gavarini, M. Seimandi, L. Vincent, J.-F. Pujol, J. Bockaert, P. Marin, and M. J. Millan
Inverse Agonist and Neutral Antagonist Actions of Antidepressants at Recombinant and Native 5-Hydroxytryptamine2C Receptors: Differential Modulation of Cell Surface Expression and Signal Transduction
Mol. Pharmacol., March 1, 2008; 73(3): 748 - 757.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. B. Fink and M. Gothert
5-HT Receptor Regulation of Neurotransmitter Release
Pharmacol. Rev., December 1, 2007; 59(4): 360 - 417.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Carlsson, M. Carta, C. Winkler, A. Bjorklund, and D. Kirik
Serotonin Neuron Transplants Exacerbate L-DOPA- Induced Dyskinesias in a Rat Model of Parkinson's Disease
J. Neurosci., July 25, 2007; 27(30): 8011 - 8022.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J.-C. Martel, A.-M. Ormiere, N. Leduc, M.-B. Assie, D. Cussac, and A. Newman-Tancredi
Native Rat Hippocampal 5-HT1A Receptors Show Constitutive Activity
Mol. Pharmacol., March 1, 2007; 71(3): 638 - 643.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Urban, W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al.
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Gavarini, C. Becamel, C. Altier, P. Lory, J. Poncet, J. Wijnholds, J. Bockaert, and P. Marin
Opposite Effects of PSD-95 and MPP3 PDZ Proteins on Serotonin 5-Hydroxytryptamine2C Receptor Desensitization and Membrane Stability
Mol. Biol. Cell, November 1, 2006; 17(11): 4619 - 4631.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Berg, S. Navailles, T. A. Sanchez, Y. M. Silva, M. D. Wood, U. Spampinato, and W. P. Clarke

J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 260 - 268.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
J. C. Talpos, L. S. Wilkinson, and T. W. Robbins
A comparison of multiple 5-HT receptors in two tasks measuring impulsivity
J Psychopharmacol, January 1, 2006; 20(1): 47 - 58.
[Abstract] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-